Table 5.
Biomarker | CVI (%) Pub. Our |
CVG (%) Pub. Our |
Subject/ Visit/Period (6 m + 6f) / (6v-6w) |
Reference | ||
---|---|---|---|---|---|---|
Adiponectin | 18.8 | 15.9 | 51.2 | 48.1 | (7 m + 15f)/(2v-15mo) | Shand et al. [14] |
IL-1β | 30.0 | 30.9 | 36.0 | 27.0 | (4 m + 11f)/(6v-6mo) | Gonzalez et al. [15] |
IL-8 | 24.0 | 54.4 | 31.0 | 30.2 | (4 m + 11f)/(6v-6mo) | Gonzalez et al. [15] |
IL-6 | 48.5 | 21.5 | 39.4 | 26.4 | (4 m + 11f)/(6v-6mo) | Cava et al. [16] |
TNF-α | 43.0 | 12.7 | 29.0 | 27.2 | (4 m + 11f)/(6v-6mo) | Gonzalez et al. [15] |
sIL-2Rα | 5.8 | 15.1 | 38.8 | 41.7 | (4 m + 11f)/(6v-6mo) | Cava et al. [16] |
sCD163 | 9.0 | 15.9 | 35.9 | 48.1 | (0 m + 12f)/(12v-35d) | Moller et al. [17] |
m male, f female, v visit, w week, mo month, Pub published data, Our our data, d day